![Nicole Lemerond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/07/2026
Nicole Lemerond is currently an Independent Director at InMed Pharmaceuticals, Inc. since 2022, MediciNova, Inc. since 2023, and GeoVax Labs, Inc. since 2022.
Formerly, Ms. Lemerond was Managing Partner at NV Capital Management from 2010 to 2022.
Ms. Lemerond completed undergraduate education at Cornell University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDICINOVA, INC. -.--% | 23/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
GEOVAX LABS, INC. -.--% | 17/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| 19/12/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Director/Miembro de la Junta | 08/08/2022 |
| GEOVAX LABS, INC. | Director/Miembro de la Junta | 31/08/2022 |
| MEDICINOVA, INC. | Director/Miembro de la Junta | 04/08/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
NV Capital Management | Corporate Officer/Principal | 01/08/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
InMed Pharmaceuticals, Inc.
 InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
MediciNova, Inc.
 MediciNova, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops novel therapeutics for the treatment of neurological and other disorders | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeoVax Labs, Inc.
 GeoVax Labs, Inc. BiotechnologyHealth Technology Develops vaccines for diseases caused by Human Immunodeficiency Virus and other infectious agents | Health Technology |
NV Capital Management |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
